文献速递妇科

预测初次肿瘤细胞减灭术后结局的模型:预测不满意肿瘤细胞减灭与肉眼残留病灶模型的独立验证

Models to predict outcomes after primary debulking surgery: Independent validation of models to predict suboptimal cytoreduction and gross residual disease.
PubMed 文献 · Gynecol Oncol · 2019-04-16

研究纳入2003至2011年接受初次肿瘤细胞减灭术的IIIC/IV期卵巢癌患者276例,独立验证两个已发表的CT预测模型。预测残留病灶>1 cm的模型验证不佳,c-index为0.653,低于开发队列的0.758,且高估了残留病灶>1 cm的比例;预测肉眼残留病灶的模型区分度优秀,c-index为0.762。

要点

  • 预测肉眼残留病灶的CT模型在独立中心验证成功,c-index为0.762。
  • 预测残留病灶>1 cm的模型验证不佳,c-index为0.653,低于开发队列的0.758。
  • 作者认为预测肉眼残留病灶的模型可帮助晚期卵巢癌的临床决策。

核心结论

  • 作者能够在独立中心验证预测肉眼残留病灶的CT模型;预测残留病灶>1 cm的独立模型未通过验证。
  • 作者认为应用预测肉眼残留病灶的模型可帮助晚期卵巢癌的临床决策。

研究设计与样本

  • 研究纳入2003至2011年接受初次肿瘤细胞减灭术的IIIC/IV期卵巢癌患者,验证队列共276例,中位年龄64岁,多数为浆液性组织学。
  • 将两个包含影像和临床变量、分别预测残留病灶>1 cm和任何肉眼残留病灶的已发表预测模型应用于该队列,由两名放射科医生对CT进行评分。

主要发现

  • 验证队列与模型开发队列的基线特征相似,但残留病灶率不同:验证队列 vs 开发队列,残留病灶>1 cm为9.4% vs 25.4%,肉眼残留病灶为50.7% vs 66.6%。
  • 预测残留病灶>1 cm的模型1验证不佳,验证队列c-index为0.653,低于开发队列报告的0.758,且模型高估了残留病灶>1 cm的比例。
  • 预测肉眼残留病灶的模型2区分度优秀,c-index为0.762。

关键数值与推荐

  • 预测残留病灶>1 cm的模型1:验证队列c-index为0.653,开发队列为0.758。
  • 预测肉眼残留病灶的模型2:验证队列c-index为0.762。

临床怎么用

  • 作者认为应用预测肉眼残留病灶的模型可帮助晚期卵巢癌的临床决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Treatment planning requires accurate estimation of surgical complexity (SC) and residual disease (RD) at primary debulking surgery (PDS) for advanced ovarian cancer (OC). We sought to independently validate two published computed tomography (CT) prediction models. METHODS: We included stage IIIC/IV OC patients who underwent PDS from 2003 to 2011. Two prediction models which included imaging and clinical variables to predict RD > 1 and any gross RD, respectively, were applied to our cohort. Two radiologists scored CTs. Discrimination was estimated using the c-index and calibration were assessed by comparing the observed and predicted estimates. RESULTS: The validation cohort consisted of 276 patients; median age of the cohort was 64 years old and majority had serous histology. The validation and model development cohorts were similar in terms of baseline characteristics, however the RD rates differed between cohorts (9.4% vs 25.4% had RD >1 cm; 50.7% vs. 66.6% had gross RD). Model 1, the model to predict RD >1 cm, did not validate well. The c-index of 0.653 for the validation cohort was lower than reported in the development cohort (0.758) and the model over-predicted the proportion with RD >1 cm. The second model to predict gross RD had excellent discrimination with a c-index of 0.762. CONCLUSIONS: We are able to validate a CT model to predict presence of gross RD in an independent center; the separate model to predict RD >1 cm did not validate. Application of the model to predict gross RD can help with clinical decision making in advanced ovarian cancer.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Kumar A, Sheedy S, Kim B, et al. Models to predict outcomes after primary debulking surgery: Independent validation of models to predict suboptimal cytoreduction and gross residual disease. Gynecol Oncol. 2019. PMID: 31000471. doi:10.1016/j.ygyno.2019.04.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。